Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues

Stopped early

Conditions studied: Known or Suspected Dysplasia or Cancer

In brief

The overall objective of this exploratory, laboratory study is to evaluate whether noninvasive fluorescence microendoscopic imaging of tissue can assist clinicians in detecting dysplastic (precancerous) areas during standard surveillance. This is a study designed to evaluate the feasibility of using prototype imaging technology to enhance the detection of precancerous changes in various tissues. The results of this laboratory study will be used to further develop the technology for clinical application. The primary aim of this project will be to investigate what digital image analysis criteria can be used to best detect dysplasia in various types of resected tissue.

Key facts

Study ID

NCT01968863

Run by

University of Arkansas

People needed

13

Starts

2013-11-01

Expected to finish

2015-07-01

Last updated by the study team

2015-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females over the age of 18 scheduled for standard of care resection of abnormal tissue

You may not qualify if…

• Previous chemotherapy or radiation treatment to the tissue to be resected
• Inability to provide consent

Where it is running

• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.